| Sandoz International GmbH - SWOT Analysis | | | | manufacturing more complex generics in different |
| company profile is the essential source for | | | | delivery systems including patches and inhalers. It |
| top-level company data and information. Sandoz | | | | has operations in more than 130 countries. It is |
| International GmbH - SWOT Analysis examines | | | | headquartered in Holzkirchen, Germany and |
| the company's key business structure and | | | | employed 23,146 people as of December 2008. |
| operations, history and products, and provides | | | | The company recorded revenues of $7,557 million |
| summary analysis of its key revenue lines and | | | | during the financial year (FY) ended December |
| strategy. | | | | 2008, an increase of 5.4% over FY2007. The |
| Sandoz, the generic business division of Novartis, | | | | increase was mainly due to the significant growth |
| is engaged in the development, manufacture and | | | | in product sales in the US. The operating profit of |
| marketing of generic medicines as well as | | | | the company was $1,084 million during FY2008, |
| pharmaceutical and biotechnological active | | | | an increase of 4.3% over FY2007. |
| ingredients. The company has expertise in | | | | |